Corient Capital Partners, LLC Becton Dickinson & CO Transaction History
Corient Capital Partners, LLC
- $1.34 Billion
- Q3 2022
A detailed history of Corient Capital Partners, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Corient Capital Partners, LLC holds 4,687 shares of BDX stock, worth $1.08 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,687
Previous 4,574
2.47%
Holding current value
$1.08 Million
Previous $1.13 Million
2.48%
% of portfolio
0.09%
Previous 0.09%
Shares
16 transactions
Others Institutions Holding BDX
# of Institutions
1,754Shares Held
254MCall Options Held
650KPut Options Held
641K-
Vanguard Group Inc Valley Forge, PA26.6MShares$6.14 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$5.15 Billion0.12% of portfolio
-
State Street Corp Boston, MA13.8MShares$3.2 Billion0.14% of portfolio
-
Morgan Stanley New York, NY11.3MShares$2.62 Billion0.21% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.7MShares$2.48 Billion0.3% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $65.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...